Pulsed Dye Laser in Treating Patients With Post Radiation Dysphonia
Status: | Completed |
---|---|
Conditions: | Cancer, Cancer, Cancer, Cancer, Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | Any |
Updated: | 7/5/2018 |
Start Date: | October 2009 |
End Date: | June 2016 |
Pulsed Dye Laser for Treatment of Post Radiation Dysphonia
This pilot trial studies pulsed dye laser in treating patients with post radiation dysphonia.
Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk,
such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens
after radiation therapy for laryngeal cancer. Pulsed dye laser may improve post radiation
dysphonia.
Dysphonia, or vocal cord scarring, can include trouble with the voice when trying to talk,
such as hoarseness, change in voice pitch, and poor voice quality, and it commonly happens
after radiation therapy for laryngeal cancer. Pulsed dye laser may improve post radiation
dysphonia.
PRIMARY OBJECTIVES:
I. To evaluate the use of pulsed dye laser in treatment of the dysphonia that commonly
results after radiation therapy for laryngeal carcinoma.
OUTLINE:
Patients undergo pulsed dye laser monthly for three months.
After completion of study treatment, patients are followed up at 1, 3, and 6 months.
I. To evaluate the use of pulsed dye laser in treatment of the dysphonia that commonly
results after radiation therapy for laryngeal carcinoma.
OUTLINE:
Patients undergo pulsed dye laser monthly for three months.
After completion of study treatment, patients are followed up at 1, 3, and 6 months.
Inclusion Criteria:
- Patients suffering from dysphonia after radiation therapy for glottic carcinoma will
be included in the study
- Patients will be included if their initial stage was T1 N0 M0 or T2 N0 M0
Exclusion Criteria:
- Patients having previously undergone large surgical resections of the larynx or
hypopharynx will be excluded
- Patients fewer than 1 year out from completion of radiation therapy will be excluded
- Patients with local disease recurrence would be excluded from the trial
- Patients in whom the transnasal endoscope is poorly tolerated or patients in whom
transnasal endoscopic laryngoscopy is contraindicated will be excluded
We found this trial at
1
site
Medical Center Boulevard
Winston-Salem, North Carolina 27157
Winston-Salem, North Carolina 27157
336-716-2255
Comprehensive Cancer Center of Wake Forest University Our newly expanded Comprehensive Cancer Center is the...
Click here to add this to my saved trials